[HTML][HTML] Molecular Pharmacology of Vitamin C and Relevance to Health and Obesity—A Narrative Review
The role of food constituents as pharmacological agents is an important consideration in
health and obesity. Vitamin C acts as a small molecule antioxidant but is also a co-factor for …
health and obesity. Vitamin C acts as a small molecule antioxidant but is also a co-factor for …
Inflammatory liver diseases and susceptibility to sepsis
H Lu - Clinical Science, 2024 - portlandpress.com
Patients with inflammatory liver diseases, particularly alcohol-associated liver disease and
metabolic dysfunction-associated fatty liver disease (MAFLD), have higher incidence of …
metabolic dysfunction-associated fatty liver disease (MAFLD), have higher incidence of …
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose …
diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose …
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
WPDW Thilakarathna, HPV Rupasinghe - Molecules, 2024 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, is a
spectrum of liver abnormalities ranging from steatosis to nonalcoholic steatohepatitis …
spectrum of liver abnormalities ranging from steatosis to nonalcoholic steatohepatitis …
[HTML][HTML] Efficacy and Safety of Aldafermin in Non-Alcoholic Steatohepatitis: A systematic review and meta-analysis of randomized controlled trials
Background Non-alcoholic steatohepatitis (NASH) is an advanced subtype of non-alcoholic
fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high …
fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high …
[PDF][PDF] Clinics and Research in Hepatology and Gastroenterology
MM Marey, M Belal, AA Awad - researchgate.net
Background: Non-alcoholic steatohepatitis (NASH) is an advanced subtype of non-alcoholic
fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high …
fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high …
[HTML][HTML] Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping
S Habib - World Journal of Gastrointestinal Pathophysiology, 2024 - ncbi.nlm.nih.gov
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread global
disease with significant health burden. Unhealthy lifestyle, obesity, diabetes mellitus (DM) …
disease with significant health burden. Unhealthy lifestyle, obesity, diabetes mellitus (DM) …
[引用][C] Liver hypercortisolism as a potential target for MASH treatment—Authors' reply
Y Kim, I Hwang, SW Lee - Alimentary Pharmacology & …, 2023 - Wiley Online Library
Editorial: Liver hypercortisolism as a potential target for MASH treatment—Authors' reply
Page 1 1240 | wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2023;58:1240–1241 …
Page 1 1240 | wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2023;58:1240–1241 …